ReviewHealthcare (Basel, Switzerland)2026
Impact of Glycemic Trajectory and Variability on Ischemic Stroke Prognosis and Exploration of Its Mechanisms: A Comprehensive Review.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The association between glycemic trajectories and variability with new-onset stroke and stroke outcomes remains poorly understood. Previous studies have predominantly focused on the absolute levels of single-point glucose measurements and emphasized mean glucose levels, overlooking individual differences in baseline levels and variability. This study describes prior research exploring the relationship between glucose trajectories and variability with post-stroke hemorrhagic transformation, short- and long-term clinical outcomes, post-stroke pain, post-stroke depression, and post-stroke cognitive impairment. It also discusses approaches to achieving precise and standardized measurement of glucose trajectories and variability, as well as existing methods for effectively improving glucose fluctuations. The findings suggest that abnormal glucose trajectories and high variability are independently associated with adverse stroke outcomes. However, significant gaps remain regarding standardization of variability metrics, integration of continuous glucose monitoring into acute stroke care, and the lack of prospective interventional data. Future research should prioritize the establishment of unified assessment standards and well-designed prospective studies to translate these findings into clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.